Controller-approved source entry - manual review required Feline Hematology Manual reviewPractice focus

Feline anemia, hemotropic infection, and transfusion safety

Separate anemia driver, instability signals, and support boundary before definitive interventions.

⏱ 6-8 min read · Topic 90 of 141

Practice Qs

Traps

Moderate to high

Exam freq.

—

Your status

Study step

Classic NAVLE presentation

Immediate priority

Perfusion, mentation, respiratory effort, and active bleeding determine whether stabilization or transfusion planning outranks etiologic certainty.

Mechanism split

Start with PCV/TS, reticulocytes, smear, bilirubin/urine color, and regeneration before disease-specific testing.

Hemoplasma clue

Flea/tick exposure, outdoor status, fever, regenerative hemolysis, and smear/PCR context keep hemotropic Mycoplasma in the lane.

Transfusion safety

Cats require blood typing and compatible donor selection; previous transfusion or uncertain history makes compatibility discipline essential.

Clinical caution

This page teaches NAVLE-style decisions and intentionally avoids dosing-by-weight drug or transfusion protocols.

High-yield takeaways

Recognize the classic presentation, then narrow the case using signalment, timeline, exam findings, diagnostics, and response to treatment.
Use the decision framework, traps, differentials, and related questions to rehearse NAVLE-style next-best-step reasoning.
This educational study page is not a clinical protocol; confirm patient-specific decisions with current references and clinician judgment.

30-second revision

First actionPerfusion and mentation before final branch closure.

BranchingKeep loss, hemolysis, marrow suppression, and infection separate initially.

Transfusion logicSupport, not guarantee, while risk and cause are clarified.

MonitoringUse serial trend language in unstable cats.

CautionClinical doses and treatment thresholds remain case-specific.

How NAVLE tests this topic

Primary discriminator → Is oxygen delivery unstable enough that stabilization or transfusion planning is the next-best-step before full cause confirmation?

PCV/TS branch → Low PCV with low total solids points toward blood loss; icterus/pigment without low solids points toward hemolysis.

Regeneration branch → Regenerative anemia prioritizes loss or hemolysis; nonregenerative anemia pushes FeLV/FIV, chronic inflammation, CKD, marrow disease, or iron deficiency.

Transfusion branch → The tested safety move is type, compatibility, monitoring, and cause control; transfusion does not replace diagnosis.

Infectious branch → Hemoplasma PCR/smear context, retroviral testing, parasite exposure, and immune status change treatment and recurrence thinking.

Emergency Triage Alert

Immediate safety first

Acute instability in feline anemia or hemoparasitic disease can progress quickly. This page is educational and does not provide patient-specific medication doses.

Clinical review note

Safety and source discipline

Use this page as educational reasoning practice. Confirm blood transfusion criteria, anticoagulant risk discussions, and anti-infective plans from current feline references before clinical use.

Key clinical patterns

Core pattern

Acute collapse with pale mucous membranesWeakness with hidden bleeding riskIcterus and red-flag perfusion changesInfectious exposure or recent tick travel historyNon-regenerative clues with chronic signs

Supporting clues

Perfusion trend over timeTimeline and onset speedBleeding source and progressionParasite and infection contextEscalation trigger language in stem

NAVLE trigger: NAVLE logic usually checks whether candidates keep branches separate before choosing the next best action.

Decision framework - what NAVLE asks

Acute unstable anemia

If mentation, pulses, respiratory effort, or collapse indicate poor oxygen delivery, stabilize and plan compatible transfusion support while cause testing begins.

PCV low with total solids low

Prioritize blood-loss sources such as GI hemorrhage, fleas, trauma, surgery, coagulopathy, or hematuria rather than hemolysis-only answers.

PCV low with icterus or hemolysis clues

Prioritize hemolysis workup: smear review, bilirubin/urine color, autoagglutination, hemoplasma testing, retroviral context, and immune-mediated clues.

Nonregenerative anemia pattern

Do not give hemolysis answers by reflex; pursue FeLV/FIV, CKD, chronic inflammation, iron deficiency, and marrow disease lanes.

Transfusion safety branch

Before feline transfusion, choose type/compatibility discipline and monitoring; incompatible blood is the dangerous exam trap.

Diagnostic priorities and interpretation

PCV/hematocrit severity

Urgency hinge

Interpret with clinical signs; severe anemia plus instability changes the answer toward support before complete etiologic certainty.

Total solids/protein

Loss-vs-lysis hinge

Low protein with low PCV supports blood loss; normal protein with icterus supports hemolysis or production failure depending on regeneration.

Reticulocytes and smear

Regeneration hinge

Regenerative response, RBC parasites, agglutination, spherocytes, Heinz bodies, or platelet abnormalities redirect the branch.

Bilirubin, urine color, autoagglutination

Hemolysis hinge

Icterus, pigmenturia, and immune-mediated clues separate hemolysis from occult hemorrhage and marrow disease.

FeLV/FIV and hemoplasma testing

Cause hinge

Retroviral status and PCR/smear context matter when anemia is regenerative, recurrent, febrile, or exposure-linked.

Blood type/crossmatch

Safety hinge

Feline transfusion decisions require compatible blood and monitoring for reaction, especially with previous transfusion history.

Manual-review caution: confirm local transfusion and antimicrobial pathways with current feline references.

Treatment escalation and management logic

Immediate

Minimize stress, support oxygen delivery, reassess perfusion/mentation, control visible hemorrhage, and prepare compatible transfusion if instability is severe.

This page focuses on decision sequencing, not fixed transfusion or medication dosing.

Diagnostic narrowing

Use PCV/TS, reticulocytes, smear, bilirubin/urine color, coagulation/bleeding search, FeLV/FIV, and hemoplasma PCR/smear context to name the mechanism.

Cause remains uncertain in many stems; mechanism sorting prevents premature closure.

Cause-directed treatment

Treat hemorrhage source, hemoplasma/vector context, immune-mediated disease, renal/chronic disease, iron deficiency, or marrow disease after the mechanism is supported.

Do not give one generic anemia plan for every cat.

Transfusion monitoring

Use type-compatible blood, careful monitoring, and reaction recognition; transfusion buys time while the underlying cause is addressed.

The exam trap is treating transfusion as definitive cure or skipping compatibility.

Recovery planning

Trend PCV/TS, reticulocytes, body weight, flea/vector control, retroviral status, and recurrence warning signs.

Escalation should remain available if anemia progresses or reaction signs appear.

NAVLE traps — where students lose marks

Assuming rapid hemolysis and rapid hemorrhage are the same branch

The immediate action logic is shared but the pathway emphasis differs, especially when transfusion timing is discussed.

Ignoring early perfusion decline while investigating

Unsafe delay occurs when candidates prioritize etiologic certainty before stabilization checks.

Treating transfusion as guaranteed curative

It supports stability and time while broader interpretation and monitoring continue.

Skipping infection context in feline weak-cat stems

Hemotropic infection or vector context can change the branch order and urgency language.

Selecting a protocol-only answer

Question stems usually score clinical sequencing and risk-aware decisioning, not dose memorization.

Overcommitting to one rare condition without instability evidence

Common high-yield branches must still be ruled in order before exotic anchors.

Differential diagnosis framework

Sorting rule: evaluate instability and cause family (loss, hemolysis, suppression, infection) before definitive treatment choice.

Branch	Signal	Best discriminator	Trap
Acute blood-loss anemia	Collapse, weakness, trauma/GI bleed/fleas, low PCV and low total solids	Bleeding source search plus PCV/TS trend	Calling it immune hemolysis from pallor alone
Hemotropic mycoplasma-associated hemolysis	Outdoor/flea/tick exposure, fever, regenerative anemia, smear/PCR context	PCR or smear interpreted with clinical stage and concurrent disease	Assuming a negative smear excludes disease
Immune-mediated hemolysis	Regeneration, icterus, agglutination/spherocytes, no obvious blood loss	Autoagglutination/smear plus exclusion of triggers	Treating before checking infectious/toxic triggers
Marrow suppression / chronic disease	Nonregenerative anemia, chronic illness, CKD, FeLV/FIV, weight loss	Reticulocyte response with retroviral/renal/chronic disease workup	Expecting acute hemolysis signs in a production problem
Coagulopathy or platelet disorder	Bleeding pattern, petechiae, melena, anticoagulant/toxin or liver disease clues	Platelets, coagulation tests, and bleeding-site evidence	Transfusing without investigating ongoing loss
Transfusion reaction risk	Prior transfusion, unknown type, acute support need	Blood type/crossmatch and monitoring plan	Treating compatibility as optional in cats